BioCentury
ARTICLE | Company News

Abgenix, Microscience deal

May 12, 2003 7:00 AM UTC

Microscience will use its vaccine target identification platforms to supply infectious disease target antigens to ABGX, which will use its XenoMouse technology to generate antibodies. The companies wi...